MAUDE Adverse Event Report: CERENOVUS, INC. CEREGLIDE; CATHETER, THROMBUS RETRIEVER CATHETER, PERCUTANEOUS, NEUROVASCULATURE

Catalog Number	NIC71132U
Medical Device Problem Code	Crack (1135)
Health Effect - Clinical Code	No Clinical Signs, Symptoms or Conditions (4582)
Date of Event	09/08/2025
Type of Reportable Event	Malfunction
Event or Problem Description
It was reported, via a healthcare professional, that this was a mechanical thrombectomy to treat a stroke in the right primary motor cortex (rm1) region.The hub of a 132cm cereglide 71 catheter (nic71132u, 31395153) cracked after multiple uses.It was replaced with another cereglide 71 132cm (c71) catheter and procedure was finished.Access was made from the femoral artery.The cereglide 71 catheter was used a 6 as well.5x45cm embotrap.The technologist believes one pass was made with the c71 aspiration only and then one pass with embotrap and some clots were removed.When attempting third pass prior to using- hub was noticed leaking so it was removed and bagged.A new c71 was used on next aspiration pass and vessel was open with good results and patient doing well.Additional event information received on 17-sep-2025 indicated that there was no alleged product malfunction with the embotrap, however, not all the clot was captured.The hub crack was noted when the user was going to do another aspiration attempt with catheter following embotrap pass.It was further noted that when getting prepared to do another pass with c71 outside the body notice leaking of saline from hub/strain relief area.There was no excessive force been inadvertently applied on the device.The device deficiency did not result in patient harm; the patient is doing well.The vessel was opened and with good results.
Additional Manufacturer Narrative
Manufacturer ref# (b)(4).Information regarding patient weight, height, medical history and race.Section d2b: procode is nry/qjp.Section h3 - the device is available to be returned for evaluation and testing.However, it has not been received to date.If the device returns, a device investigation will be performed.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
Additional Manufacturer Narrative
Manufacturer ref# (b)(4) updated sections on this medwatch: b4, d9, g3, g6, h2, h3, h6 and h11.Complaint conclusion: it was reported, via a healthcare professional, that this was a mechanical thrombectomy to treat a stroke in the right primary motor cortex (rm1) region.The hub of a 132cm cereglide 71 catheter (nic71132u, 31395153) cracked after multiple uses.It was replaced with another cereglide 71 132cm (c71) catheter and procedure was finished.Access was made from the femoral artery.The cereglide 71 catheter was used as well a 6.5x45cm embotrap.The technologist believes one pass was made with the c71 aspiration only and then one pass with embotrap and some clots were removed.When attempting third pass prior to using- hub was noticed leaking so it was removed and bagged.A new c71 was used on next aspiration pass and vessel was open with good results and patient doing well.Additional event information received on 17-sep-2025 indicated that there was no alleged product malfunction with the embotrap, however, not all the clot was captured.The hub crack was noted when the user was going to do another aspiration attempt with catheter following embotrap pass.It was further noted that when getting prepared to do another pass with c71 outside the body notice leaking of saline from hub/strain relief area.There was no excessive force been inadvertently applied on the device.The device deficiency did not result in patient harm; the patient is doing well.The vessel was opened and with good results.The device was returned to j&j medtech for evaluation.One non-sterile 132cm cereglide 71 catheter was returned in the decontamination pouch.Upon receipt of the device, visual inspection was performed, and the hub was noted to be loose.No other damage was found in the device.Microscopic examination was performed.Under magnification, it was noted that the hub had been subjected to force, which caused the outer plastic layer to fracture, exposing the internal wires.However, the device remained in one piece connected by the internal braided wires.The issue reported that the device was broken at the hub was confirmed during the inspection.According to risk documentation hub damage during attachment of hemostasis valve is a potential failure mode that can result from the handling of hemostasis valve and hub, where excessive force could have been applied, leading to damage to the device.Devices undergo 100% inspection for exposed wire inside the hub during hub injection molding process, and 100% inspection for catheter kinks or damage during catheter loading into hoop.Thus, it is not likely that the device left the facility in a damaged condition; intra-operative factors may have contributed to the issue reported, however, with the amount of information available, a root cause cannot be established.A manufacturing record evaluation was performed for the finished device 31395153 number, and internal actions related to the malfunction were identified.As part of the j&j medtech quality process, all devices are manufactured, inspected, and released to approved specifications.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no internal action activity is required.Although no conclusion could be reached as to the cause of the event reported, the instructions for use (ifu) contains the following precautions: - before removing the intermediate catheter from the packaging hoop dispenser, rotate the luer on the packaging hoop 90 degrees.- gently remove the catheter and accessories from the hoop and inspect prior to use to verify that they are undamaged.Caution: do not use a catheter that has been damaged in any way.If damage is detected, replace with another catheter that is not damaged.Do not advance or withdraw an intravascular device against resistance until the cause of the resistance is determined by fluoroscopy.Movement of the device against resistance could damage the device or cause patient injury.As part of the post market surveillance program, information from this complaint is trended to identify statistical signals for consideration of further correction action.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.

• Brand Name: CEREGLIDE
• Common Device Name: CATHETER, THROMBUS RETRIEVER CATHETER, PERCUTANEOUS, NEUROVASCULATURE
• Manufacturer (Section D): CERENOVUS, INC.; 6303 waterford district drive; suites 215 & 315; miami FL 33126
• Manufacturer (Section G): CERENOVUS INC. (JUAREZ); circuito interior norte #1820; parque industrial salvarcar; juarez chihuahua 32574 ; MX 32574
• Manufacturer Contact: henry boden ; 31 technology dr; irvine, CA 92618 ; 9497882078
• MDR Report Key: 23097096
• Report Number: 3007628272-2025-00049
• Device Sequence Number: 21178011
• Product Code: NRY
• UDI-Device Identifier: 10886704085409
• UDI-Public: (01)10886704085409(17)270630(10)31395153
• Combination Product (Y/N): N
• Initial Reporter State: OH
• Initial Reporter Country: US
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: Other,Health Professional
• Initial Reporter Occupation: Other Health Care Professional
• Type of Report: Initial,Followup
• Report Date (Section B): 10/16/2025

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Catalogue Number: NIC71132U
• Device Lot Number: 31395153
• Was Device Available for Evaluation?: Device Returned to Manufacturer
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 09/10/2025
• Supplement Date Received by Manufacturer: 09/30/2025
• Initial Report FDA Received Date: 09/19/2025
• Supplement Report FDA Received Date: 10/16/2025
• Was Device Evaluated by Manufacturer? (Y/N): Yes
• Date Device Manufactured: 07/16/2024
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: EMBOTRAP
• Patient Age: 59 YR
• Patient Sex: Male
• Patient Race: Black Or African American